My serials Follow this serial

De Gruyter

Forum for Health Economics & Policy

Contact information of De Gruyter

Serial Information

Order information:
Web: https://www.degruyter.com/view/j/fhep
Download restrictions: For access to full text, subscription to the journal or payment for the individual article is required.
Editor: Dana Goldman

Additional information is available for the following registered editor(s): Dana P. Goldman .
Series handle: RePEc:bpj:fhecpo

Citations RSS feed: at CitEc

Impact factors

Access and download statistics
Top item:

By citations
By downloads (last 12 months)

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bpj:fhecpo. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.degruyter.com .

Content

December 2020, Volume 23, Issue 2

1-23 The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population
by Sullivan Jeffrey & Shih Tiffany M. & van Eijndhoven Emma & Lakdawalla Darius N. & Benner Jennifer & Jalundhwala Yash J. & Zadikoff Cindy & Marshall Thomas S. & Sail Kavita R.

June 2020, Volume 23, Issue 1

1-14 Health Economics Tools and Precision Medicine: Opportunities and Challenges
by Veenstra David L. & Basu Anirban & Mandelblatt Jeanne & Neumann Peter & Peterson Josh F. & Ramsey Scott D.
1-14 Switching Costs in Medicare Advantage
by Atherly Adam & van den Broek-Altenburg Eline & Feldman Roger D. & Dowd Bryan
1-15 Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis
by Snyder Sophie & Gitlin Matthew & Hollenbeak Christopher S. & Kalantar-Zadeh Kamyar & Ashfaq Akhtar

December 2019, Volume 22, Issue 2

1-11 Billing Codes Determine Lower Physician Income for Primary Care and Non-Procedural Specialties
by Langer Arielle L. & Laugesen Miriam
1-20 The Impact of Medical Marijuana Laws and Dispensaries on Self-Reported Health
by Andreyeva Elena & Ukert Benjamin

June 2019, Volume 22, Issue 1

1-13 Modeling Product Choices in a Peer Network
by Fang Di & Richards Timothy J. & Grebitus Carola
1-36 Is Primary Care A Substitute or Complement for Other Medical Care? Evidence from Medicaid
by Chen Jiajia & van den Berghe Eunkyung & Kaestner Robert

December 2018, Volume 21, Issue 2

1-20 The Impact of Affordable Care Act Medicaid Expansions on Applications to Federal Disability Programs
by Anand Priyanka & Hyde Jody Schimmel & Colby Maggie & O’Leary Paul
1-20 The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis
by Lichtenberg Frank R.
1-24 Health insurance coverage and health care utilization: Evidence from the Affordable Care Act’s dependent coverage mandate
by Yörük Barış K.
1-27 Short-Run Health Consequences of Retirement and Pension Benefits: Evidence from China
by Nikolov Plamen & Adelman Alan

June 2018, Volume 21, Issue 1

1-10 The Option Value of Innovative Treatments for Metastatic Melanoma
by Thornton Snider Julia & Seabury Seth & Tebeka Mahlet Gizaw & Wu Yanyu & Batt Katharine
1-11 The Value of the Health and Retirement Study for Health Economics Research
by Coile Courtney C. & Maestas Nicole
1-14 Disability Measurement in the Health and Retirement Study
by Agree Emily M. & Wolf Douglas A.

December 2017, Volume 20, Issue 2

1-12 Using the Health and Retirement Study for Disability Policy Research: A Review
by Schimmel Hyde Jody & Stapleton David C.
1-16 The Accuracy of Economic Measurement in the Health and Retirement Study
by French Eric & Jones John Bailey & McCauley Jeremy
1-19 The Price Elasticity of Specialty Drug Use: Evidence from Cancer Patients in Medicare Part D
by Jung Jeah & Feldman Roger D. & McBean Marshall
1-56 The Long-Term Impact of Price Controls in Medicare Part D
by Moreno Gigi & van Eijndhoven Emma & Benner Jennifer & Sullivan Jeffrey

June 2017, Volume 20, Issue 1

1-13 The Share Price Effect of CVS Health’s Announcement to Stop Selling Tobacco: A Comparative Case Study Using Synthetic Controls
by Andersen Martin & Bauhoff Sebastian
1-17 The Effect of the Health Insurance Mandate on Labor Market Activity and Time Allocation: Evidence from the Federal Dependent Coverage Provision
by Lenhart Otto & Shrestha Vinish
1-28 The Impact of Pharmaceutical Innovation on Cancer Mortality in Belgium, 2004–2012
by Lichtenberg Frank R.

December 2016, Volume 19, Issue 2

157-177 Public Provision and Cross-Border Health Care
by Granlund David & Wikström Magnus
179-199 Physician Self-Referral of Physical Therapy Services for Patients with Low Back Pain: Implications for Use, Types of Treatments Received and Expenditures
by Mitchell Jean M. & Reschovsky James D. & Franzini Luisa & Reicherter Elizabeth Anne
201-259 The ACA: Impacts on Health, Access, and Employment
by Serakos Maria & Wolfe Barbara
261-297 Estimating Regression-Based Medical Care Expenditure Indexes for Medicare Advantage Enrollees
by Hall Anne E.
299-331 Evidence of Inefficiencies in Practice Patterns: Regional Variation in Medicare Medical and Drug Spending
by Buntin Melinda & Hayford Tamara
333-351 The Impact of Delayed Hepatitis C Viral Load Suppression on Patient Risk: Historical Evidence from the Veterans Administration
by Matsuda Tara & McCombs Jeffrey S. & McGinnis Justin & Tonnu-Mihara Ivy & Fox D. Steven

June 2016, Volume 19, Issue 1

1-22 Salience and Health Campaigns
by Dertwinkel-Kalt Markus
23-43 Demand-Side Factors Associated with the Purchase of Long-Term Care Insurance
by Unruh Mark A. & Stevenson David G. & Frank Richard G. & Cohen Marc A. & Grabowski David C.
45-70 Competitive Spillovers and Regulatory Exploitation by Skilled Nursing Facilities
by Bowblis John R. & Brunt Christopher S. & Grabowski David C.
71-86 Returns to Society from Investment in Cancer Research and Development
by Chandra Amitabh & MacEwan Joanna P. & Campinha-Bacote Avrita & Khan Zeba M.
87-139 How Effective is Population-Based Cancer Screening? Regression Discontinuity Estimates from the US Guideline Screening Initiation Ages
by Kadiyala Srikanth & Strumpf Erin
141-156 Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection
by Seabury Seth A. & Goldman Dana P. & Lakdawalla Darius N. & Gupta Charu N. & Khan Zeba M. & Chandra Amitabh & Philipson Tomas J.

December 2015, Volume 18, Issue 2

75-96 Health and Health Care of Medicare Beneficiaries in 2030
by Gaudette Étienne & Tysinger Bryan & Goldman Dana P. & Cassil Alwyn
97-118 Trends in the Well-Being of the Aged and Their Prospects through 2030
by Burtless Gary
119-136 The Transformation of Medicare, 2015 to 2030
by Aaron Henry J. & Reischauer Robert
137-149 Revamping Provider Payment in Medicare
by Ginsburg Paul B. & Wilensky Gail R.
151-168 Could Improving Choice and Competition in Medicare Advantage be the Future of Medicare?
by Rivlin Alice M. & Daniel Willem

January 2015, Volume 18, Issue 1

1-24 Long-Term Effects of Tobacco Prices Faced by Adolescents
by Auld M. Christopher & Zarrabi Mahmood
25-39 The Value of Delaying Alzheimer’s Disease Onset
by Zissimopoulos Julie & Crimmins Eileen & St.Clair Patricia
41-64 Sex-selective Abortion Bans are Not Associated with Changes in Sex Ratios at Birth among Asian Populations in Illinois and Pennsylvania
by Nandi Arindam & Kalantry Sital & Citro Brian
65-74 Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets
by Chou Jacquelyn W. & Lakdawalla Darius N. & Vanderpuye-Orgle Jacqueline

September 2014, Volume 17, Issue 2

1-16 Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants
by Seabury Seth A. & Lakdawalla Darius N. & Goldman Dana P. & Walter Deborah & Hayes John & Gustafson Thomas & Shrestha Anshu
1-21 Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital?
by Lakdawalla Darius N. & Snider Julia Thornton & Linthicum Mark T. & Perlroth Daniella J. & LaVallee Chris & Philipson Tomas J. & Partridge Jamie S. & Wischmeyer Paul E.
1-25 The Effects of Smoking Cessation on Weight Gain: New Evidence Using Workplace Smoking Bans
by Fletcher Jason M.
1-27 Retail Tobacco Display Bans
by Irvine Ian J. & Nguyen Van Hai

January 2014, Volume 17, Issue 1

1-8 The Crowd, the Cloud and Improving the Future of Medical Device Innovation
by Huesch Marco & Szczerba Robert
1-12 A Note on Income Effects and Health Care Cost Growth in Medicare
by McGuire Thomas G.
1-25 Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis
by Erickson Kevin F. & Winkelmayer Wolfgang C. & Chertow Glenn M. & Bhattacharya Jay
1-26 Employment and Adverse Selection in Health Insurance
by Bhattacharya Jayanta & Vogt William B.
1-32 A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies
by Stevens Warren & Philipson Tomas & Wu Yanyu & Chen Connie & Lakdawalla Darius

September 2013, Volume 16, Issue 2

1-11 Economics of Personalized Health Care and Prevention: IntroductionThis introduction represents the personal views of the authors only and not the official policy of the National Institutes of Health or its component institutes
by Bloss Gregory & Haaga John G.
121-133 The Value of Diagnostic Testing in Personalized Medicine
by Goldman Dana P. & Lakdawalla Darius & Sood Neeraj & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Agus David & Jena Anupam B. & Philipson Tomas J.

June 2013, Volume 16, Issue 2

47-56 Opportunities in the Economics of Personalized Health Care and Prevention
by Meltzer David O.
57-86 Economic Perspectives on Personalized Health Care and Prevention
by Phillips Kathryn A. & Sakowski Julie Ann & Liang Su-Ying & Ponce Ninez A.
87-105 The Economics of Personalization in Prevention and Public Health
by Kenkel Don S. & Wang Hua
107-120 Personalized Medicine in the Context of Comparative Effectiveness Research
by Basu Anirban

April 2013, Volume 16, Issue 1

1-22 Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors
by Sood Neeraj & Philipson Tomas J. & Huckfeldt Peter

March 2013, Volume 16, Issue 1

1-19 Price Shopping in Consumer-Directed Health Plans
by Sood Neeraj & Wagner Zachary & Huckfeldt Peter & Haviland Amelia M.
1-27 The Effect of Comprehensive Smoking Bans in European Workplaces
by Origo Federica & Lucifora Claudio
1-36 Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases
by Jena Anupam B. & Mechoulan Stéphane & Philipson Tomas J.

September 2013, Volume 16, Issue 1

1-39 Why are Testing Rates so Low in Sub-Saharan Africa? Misconceptions and Strategic Behaviors
by Sterck Olivier

July 2013, Volume 16, Issue 1

1-25 Measuring the Financial Exposure from Medical Care Spending Among Families with Employer Sponsored Insurance
by Abraham Jean M. & Royalty Anne Beeson & DeLeire Thomas

May 2013, Volume 16, Issue 1

1-14 Integrating Patient Incentives with Episode-Based Payment
by Helmchen Lorens A. & Encinosa William E. & Chernew Michael E. & Hirth Richard A.
1-25 Better Quality of Care or Healthier Patients? Hospital Utilization by Medicare Advantage and Fee-for-Service Enrollees
by Nicholas Lauren Hersch

January 2013, Volume 16, Issue 1

1-33 The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files
by Lichtenberg Frank R.

November 2013, Volume 14, Issue 2

1-2 How Do Employers React to a Pay-or-Play Mandate? Early Evidence from San Francisco
by Colla Carrie H. & Dow William H. & Dube Arindrajit

September 2012, Volume 15, Issue 3

1-22 High US Health-Care Spending and the Importance of Provider Payment Rates
by Anderson Gerard & Chalkidou Kalipso & Herring Bradley
23-52 Can Consumers Control Health-Care Costs?
by Hall Mark A. & Schneider Carl E.
53-82 Eight Decades of Discouragement: The History of Health Care Cost Containment in the USA
by Jost Timothy Stoltzfus
83-106 Both Symptom and Disease: Relating Medical Malpractice to Health-Care Costs
by Sage William M.

January 2012, Volume 15, Issue 2

1-31 Behavioral Responses of Patients in AIDS Treatment Programs: Sexual Behavior in Kenya
by Thirumurthy Harsha & Pop-Eleches Cristian & Habyarimana James P. & Goldstein Markus & Graff Zivin Joshua

March 2012, Volume 15, Issue 2

1-26 A Prescription for Drug Formulary Evaluation: An Application of Price Indexes
by Glazer Jacob & Huskamp Haiden A. & McGuire Thomas G.

February 2012, Volume 15, Issue 2

1-26 Optimal Alcohol Taxes for Australia
by Fogarty James J.

November 2012, Volume 15, Issue 2

1-13 The Value of Patent Expiration
by McKellar Michael R. & Frank Matthew & Huskamp Haiden & Chernew Michael E.
1-24 The Distributional Effects of Health Reform Limits on Flexible Spending Accounts
by Cardon James H. & Moore Joel & Showalter Mark H.
1-42 Formal and Informal Care: An Empirical Bayesian Analysis Using the Two-part Model
by Du Juan

April 2012, Volume 15, Issue 2

1-19 The Option Value of Innovation
by Thornton Snider Julia & Romley John A. & Vogt William B. & Philipson Tomas J.
1-31 Nutrient Demand in Food Away from Home
by Richards Timothy J. & Mancino Lisa & Nganje William